Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

TWD 70.7

(-3.42%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 606.71 Million 494.67 Million 411.49 Million 424.01 Million 425.33 Million
Cost of Revenue 362.07 Million 290.29 Million 239.56 Million 231.83 Million 233.89 Million
Gross Profit 244.63 Million 204.37 Million 171.92 Million 192.18 Million 191.44 Million
Operating Expenses 244.63 Million 121.7 Million 109.63 Million 116.65 Million 112.61 Million
Selling, General and Administrative Expenses 128.45 Million 108.44 Million 100.71 Million 103.57 Million 102.77 Million
Research and Development Expenses 17.26 Million 13.25 Million 8.92 Million 13.08 Million 9.83 Million
Other Expenses - 308 Thousand 161 Thousand 351 Thousand -
Cost and Expenses 507.79 Million 411.99 Million 349.2 Million 348.48 Million 346.5 Million
Operating Income 105.57 Million 83.47 Million 63.01 Million 76.86 Million 78.83 Million
Interest Expense 4.59 Million 1.05 Million 1.07 Million 792 Thousand 22 Thousand
Income Tax Expense 21.18 Million 16.68 Million 12.84 Million 12.99 Million 16.97 Million
Earnings before Tax 100.88 Million 81.53 Million 61.93 Million 76.55 Million 81.44 Million
Net Income 79.7 Million 64.85 Million 49.09 Million 63.56 Million 64.47 Million
Earnings Per Share Basic 2.24 2.16 1.49 1.92 2.15
Earnings Per Share Diluted 2.10 2.16 1.48 1.91 2.14
Weighted Average Shares Outstanding 35.61 Million 33.11 Million 33.11 Million 33.11 Million 30.12 Million
Weighted Average Shares Outstanding (Diluted) 37.97 Million 33.18 Million 33.2 Million 33.22 Million 30.11 Million
Gross Margin 0.40 0.41 0.42 0.45 0.45
EBIT Margin 0.21 0.21 0.19 0.21 0.21
Profit Margin 0.13 0.13 0.12 0.15 0.15
EBITDA 126.67 Million 101.74 Million 78.3 Million 90.1 Million 91 Million
Earnings Before Tax Margin 0.17 0.17 0.15 0.18 0.19

Income Statement Charts